Novo Nordisk shares slide after guidance disappoints investors

6 hours ago 7

Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in Copenhagen, Denmark, March 26, 2026.

Tom Little | Reuters

U.S.-traded shares of Read Entire Article